Arend, Rebecca C.

The Wnt/β-catenin pathway in ovarian cancer: A review

Arend, R. C., Londoño-Joshi, A. I., Straughn, J. M., & Buchsbaum, D. J. (2013) · Gynecologic Oncology

Wnt/β-catenin signaling in development and cancerOvarian cancer diagnosis and treatment

Cited by 458

Homologous Recombination Deficiency: Concepts, Definitions, and Assays

Stewart, M. D., Merino Vega, D., Arend, R. C., Baden, J. F., Barbash, O., Beaubier, N., Collins, G., French, T., Ghahramani, N., Hinson, P., et al. (2022) · The Oncologist

PARP inhibition in cancer therapyBRCA gene mutations in cancer

Cited by 240

Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer

Arend, R. C., Londoño-Joshi, A. I., Samant, R. S., Li, Y., Conner, M., Hidalgo, B., Alvarez, R. D., Landen, C. N., Straughn, J. M., & Buchsbaum, D. J. (2014) · Gynecologic Oncology

Wnt/β-catenin signaling in development and cancerCancer Cells and Metastasis

Cited by 161

Effect of Niclosamide on Basal-like Breast Cancers

Londoño-Joshi, A. I., Arend, R. C., Aristizabal, L., Lu, W., Samant, R. S., Metge, B. J., Hidalgo, B., Grizzle, W. E., Conner, M., Forero-Torres, A., et al. (2014) · Molecular Cancer Therapeutics

Wnt/β-catenin signaling in development and cancerCancer Cells and Metastasis

Cited by 97

Humanistic and Economic Impact of Subcutaneous Versus Intravenous Administration of Oncology Biologics

Anderson, K. C., Landgren, O., Arend, R. C., Chou, J., & Jacobs, I. A. (2019) · Future Oncology

Health Systems, Economic Evaluations, Quality of LifeEconomic and Financial Impacts of Cancer

Cited by 69